
Unilever’s under-fire boss Alan Jope today called off his dealmaking efforts after the failure of a £50 billion pursuit of GlaxoSmithKline's consumer healthcare brands.
Jope said shareholders had told him to focus on a more measured evolution of the company's portfolio, which includes the brands Marmite and Dove soap.